IBEX Financial Statements From 2010 to 2024
| IBT Stock | EUR 684.00 10.00 1.48% |
Check IBEX Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IBEX Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . IBEX financial statements analysis is a perfect complement when working with IBEX Technologies Valuation or Volatility modules.
IBEX |
IBEX Technologies Company Profit Margin Analysis
IBEX Technologies' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current IBEX Technologies Profit Margin | 0.21 % |
Most of IBEX Technologies' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IBEX Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, IBEX Technologies has a Profit Margin of 0.2147%. This is 101.92% lower than that of the Healthcare sector and 100.93% lower than that of the Biotechnology industry. The profit margin for all Germany stocks is 116.91% lower than that of the firm.
IBEX Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IBEX Technologies's current stock value. Our valuation model uses many indicators to compare IBEX Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IBEX Technologies competition to find correlations between indicators driving IBEX Technologies's intrinsic value. More Info.IBEX Technologies is rated below average in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IBEX Technologies is roughly 1.58 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IBEX Technologies' earnings, one of the primary drivers of an investment's value.About IBEX Technologies Financial Statements
IBEX Technologies stakeholders use historical fundamental indicators, such as IBEX Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although IBEX Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in IBEX Technologies' assets and liabilities are reflected in the revenues and expenses on IBEX Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IBEX Technologies. Please read more on our technical analysis and fundamental analysis pages.
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada. IBEX TECHS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in IBEX Stock
IBEX Technologies financial ratios help investors to determine whether IBEX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IBEX with respect to the benefits of owning IBEX Technologies security.